Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts (NASDAQ:TSHA)
Nadya Tkach/iStock via Getty Images Taysha Gene Therapies, Inc. (NASDAQ:TSHA) reported positive preliminary results from the phase 1/2 adolescent and ...
Saturday, February 8, 2025
Tag: NASDAQTSHA
Taysha Gene Therapies: Astellas Throws Lifeline For On Rett And GAN Programs (NASDAQ:TSHA)
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.